共 30 条
[1]
Johnson JA(2002)Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes Diabetes Care 25 2244-2248
[2]
Simpson SH(1972)A summary of criticisms of the findings of the University Group Diabetes Program Diabetes 21 976-979
[3]
Majumdar SR(1996)Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia 39 503-514
[4]
Toth EL(1998)Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853
[5]
Seltzer HS(1998)Some answers, more controversy, from UKPDS Lancet 352 832-833
[6]
Leibowitz G(1998)Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 854-865
[7]
Cerasi E(2000)Increased mortality in type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study Diabetologia 43 558-560
[8]
Nathan DM(2001)Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7 year follow-up Clin Cardiol 24 151-158
[9]
Olsson J(2004)Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study Diabetes Metab Res Rev 20 239-245
[10]
Lindberg G(1995)The Tayside Medicines Monitoring Unit (MEMO): a record-linkage system for pharmacovigilance Pharm Med 9 177-184